Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $41.33

Astrana Health, Inc. (NASDAQ:ASTH) has been assigned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $40.7778.

Several brokerages recently issued reports on ASTH. BTIG Research cut their target price on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Monday. Needham & Company LLC assumed coverage on Astrana Health in a research note on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective on the stock. Barclays reduced their target price on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Finally, TD Cowen cut their price target on Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a report on Monday, November 10th.

Astrana Health Price Performance

NASDAQ:ASTH opened at $22.32 on Friday. The stock has a market capitalization of $1.26 billion, a PE ratio of 117.48, a P/E/G ratio of 0.68 and a beta of 0.91. Astrana Health has a 1-year low of $20.12 and a 1-year high of $39.97. The firm has a fifty day simple moving average of $24.59 and a 200 day simple moving average of $26.87. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.46). The firm had revenue of $956.05 million for the quarter, compared to the consensus estimate of $952.83 million. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The business’s revenue was up 99.7% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share. On average, research analysts expect that Astrana Health will post 1.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada grew its stake in shares of Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares in the last quarter. AQR Capital Management LLC bought a new stake in Astrana Health in the 1st quarter valued at about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after purchasing an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in shares of Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after purchasing an additional 10,913 shares during the period. Finally, Intech Investment Management LLC increased its holdings in shares of Astrana Health by 5.8% during the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock worth $1,383,000 after purchasing an additional 2,462 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.